Medicare Enrolled
Dr. David Drosick, MD
Medical Oncology · Cincinnati, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Drosick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Drosick?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Drosick
Dr. David Drosick is a medical oncology specialist in Cincinnati, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Drosick performed 54,923 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Drosick received a total of $3,617 from 30 pharmaceutical and/or device companies across 86 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Drosick is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 8% volume in OH
$3,617 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗54,923
Medicare services
Top 8% in OH for medical oncology
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 16,602 | $43 | $147 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
14,280 | $0 | $6 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,400 | $0 | $6 |
| Paclitaxel chemotherapy injection | 4,632 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 2,940 | $17 | $70 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,815 | $0 | $1 |
| Iron infusion (Monoferric) | 1,300 | $17 | $75 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,070 | $1 | $122 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
994 | $8 | $35 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
865 | $10 | $62 |
| Injection, granisetron hydrochloride, 100 mcg | 800 | $0 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
778 | $60 | $205 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
376 | $94 | $686 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
350 | $91 | $305 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
265 | $2 | $300 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
233 | $21 | $152 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
183 | $7 | $462 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
181 | $11 | $105 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
138 | $13 | $58 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
133 | $10 | $93 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
125 | $45 | $304 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
124 | $9 | $54 |
| Iron level test | 123 | $6 | $26 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
121 | $9 | $34 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
90 | $24 | $141 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
83 | $16 | $78 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
83 | $47 | $334 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
78 | $0 | $5 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
73 | $88 | $300 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
68 | $17 | $111 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
60 | $1 | $7 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
55 | $1 | $19 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
48 | $130 | $410 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
42 | $19 | $96 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
38 | $21 | $156 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
38 | $58 | $210 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
37 | $2 | $19 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
36 | $14 | $97 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
32 | $39 | $281 |
| New patient office visit, complex (60-74 min) | 30 | $167 | $590 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
28 | $60 | $251 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
27 | $15 | $74 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
26 | $14 | $71 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
22 | $24 | $249 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 20 | $20 | $124 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
17 | $6 | $30 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
17 | $8 | $69 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $124 | $585 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
16 | $27 | $240 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
14 | $38 | $146 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
30.0% high complexity
62.5% medium
7.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,617
Total received (2018-2024)
Avg $603/year across 6 years
Top 45% in OH for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
86
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,666
2023
$490
2021
$171
2020
$51
2019
$122
2018
$1,116
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$857
ABBVIE INC.
$132
Merck Sharp & Dohme LLC
$88
PFIZER INC.
$69
SUN PHARMACEUTICAL INDUSTRIES INC.
$61
Gilead Sciences, Inc.
$57
AstraZeneca Pharmaceuticals LP
$54
TerSera Therapeutics LLC
$50
Lilly USA, LLC
$48
Incyte Corporation
$42
Celgene Corporation
$36
E.R. Squibb & Sons, L.L.C.
$34
Aveo Pharmaceuticals, Inc.
$25
Alnylam Pharmaceuticals Inc.
$24
GENZYME CORPORATION
$21
Stemline Therapeutics Inc.
$20
Daiichi Sankyo Inc.
$18
Astellas Pharma US Inc
$16
ARRAY BIOPHARMA INC
$14
Top 3 companies account for 64.7% of 2024 payments
All-time payments by company (2018-2024) ›
Puma Biotechnology, Inc.
$1,106
Novartis Pharmaceuticals Corporation
$936
Merck Sharp & Dohme LLC
$167
Celgene Corporation
$141
PFIZER INC.
$136
ABBVIE INC.
$132
EMD Serono, Inc.
$122
Rigel Pharmaceuticals, Inc.
$111
E.R. Squibb & Sons, L.L.C.
$90
AstraZeneca Pharmaceuticals LP
$75
Gilead Sciences, Inc.
$69
SUN PHARMACEUTICAL INDUSTRIES INC.
$61
TerSera Therapeutics LLC
$50
Lilly USA, LLC
$48
Pharmacyclics LLC, An AbbVie Company
$44
Incyte Corporation
$42
Stemline Therapeutics Inc.
$40
G1 Therapeutics, Inc.
$29
McKesson Corporation
$28
Aveo Pharmaceuticals, Inc.
$25
Alnylam Pharmaceuticals Inc.
$24
GENZYME CORPORATION
$21
Eisai Inc.
$19
Daiichi Sankyo Inc.
$18
Seagen Inc.
$17
Astellas Pharma US Inc
$16
ARRAY BIOPHARMA INC
$14
Genentech USA, Inc.
$14
Verastem, Inc.
$11
Kyowa Kirin, Inc.
$11
Top 3 companies account for 61.1% of all-time payments
Associated products mentioned in payments ›
ABECMA · COSELA · Copiktra · ENHERTU · EPKINLY · Enhertu · FARESTON · FOTIVDA · GIVLAARI · IBRANCE · IMBRUVICA · JAKAFI · KEYTRUDA · KISQALI · Lenvima · Nerlynx · OPDIVO · OXBRYTA · Odomzo · Orserdu · PEMAZYRE · Phesgo · Pomalyst · REBLOZYL · SARCLISA · SCEMBLIX · TASIGNA · TEPMETKO · TUKYSA · Tavalisse · VERZENIO · Vyloy · XALKORI · YONSA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
15
County median income
$83,178
Nearest hospital to ZIP centroid (approximate)
MERCY HEALTH-ANDERSON HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Drosick is a mixed practice specialist, with above-average Medicare volume (top 8% in OH), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Drosick experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Drosick performed 16,602 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Drosick receive payments from pharmaceutical companies?
Yes. Dr. Drosick received a total of $3,617 from 30 companies across 86 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Drosick's costs compare to other medical oncologists in Cincinnati?
Dr. Drosick's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Drosick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Cincinnati
Browse medical oncologists in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in OH
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in OH
Which OH medical oncologists receive the most from drug and device companies.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology